This is the Industrial Evolution

Eclipse is a team of operators and investors building companies that transform physical industries critical to people’s lives.

Bright Machines

Digital transformation is everywhere except for where it matters

  • Manufacturing
  • Supply Chain
  • Logistics
  • Energy
  • Healthcare
  • Defense
  • Transportation
  • Construction
  • Agriculture
  • Industrial
  • Mining

Our Companies

We partner with entrepreneurs seeking to build exceptional companies that make physical industries more efficient, resilient, and profitable

Enovix's company logo

Enovix designs advanced, 100% active silicon-anode lithium-ion batteries to power the technologies of the future.

Learn More
VulcanForms's company logo

VulcanForms builds and operates advanced digital manufacturing infrastructure.

Learn More
Vulcan Forms
Augury's company logo

Augury transforms how people work by generating insights into the health of machines and processes.

Learn More
Cellares's company logo

Cellares accelerates access to life-saving cell therapies.

Learn More

The New Economy

We need to rebuild the industries that matter.

We need critical infrastructures – in all forms – that have the resiliency, flexibility, and sustainability of digitization.

We need to create opportunities for people and bring meaningful change to our planet.

We need a new economy and we’ve started to build it.

vulcan forms

Cerebras exists to push the boundaries of what is possible and to enable our customers to explore artificial intelligence work that will transform society for the better.

Founder and CEO, Cerebras

Andrew Feldman

News & Insights

The latest news and industry perspectives from the Eclipse team

Sep 27, 2023|3 min read

Powering the Next Wave of the Marine Industry: Our Series B in Arc

Read More
Sep 7, 2023|9 min read

Electrifying the Marine Industry: Mitch Lee, Co-Founder and CEO, Arc

Read More
Aug 30, 2023|6 min read

It’s Labor Day — But Where is the Labor?

Read More
News, Portfolio
Aug 23, 2023|3 min read

Manufacturing the Future of Cell Therapy: Our Series C in Cellares

Read More